Literature DB >> 8107201

Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein.

Y Zhang1, B Y Ahn, B Moss.   

Abstract

When expression of the vaccinia virus gene encoding RAP94 (a protein that is associated with the viral multisubunit RNA polymerase and confers transcriptional specificity for early promoters) was repressed, the infectious virus yield was reduced by more than 99%. Nevertheless, intermediate- and late-stage viral gene expression and formation of ultrastructurally mature, membrane-enveloped virions occurred under the nonpermissive conditions. The RAP94-deficient particles contained the viral genome, structural proteins, early transcription factor, and certain enzymes but, unlike normal virions, had low or undetectable amounts of the viral RNA polymerase, capping enzyme/termination factor, poly(A) polymerase, DNA-dependent ATPase, RNA helicase, and topoisomerase. The presence of these viral enzymes in the cytoplasm indicated that RAP94 is required for targeting a complex of functionally related proteins involved in the biosynthesis of mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107201      PMCID: PMC236590     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  The insertion of DNA into vaccinia virus.

Authors:  C Morgan
Journal:  Science       Date:  1976-08-13       Impact factor: 47.728

2.  Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.

Authors:  K Essani; S Dales
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

3.  Reactivation of transcription from a vaccinia virus early promoter late in infection.

Authors:  J Garcés; K Masternak; B Kunz; R Wittek
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka; G Spizz
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

5.  Characterization of a polyriboadenylate polymerase from vaccinia virions.

Authors:  B Moss; E N Rosenblum; A Gershowitz
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

6.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

7.  Eukaryotic mRNA capping enzyme-guanylate covalent intermediate.

Authors:  S Venkatesan; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus.

Authors:  J R Morgan; L K Cohen; B E Roberts
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions.

Authors:  G Rohrmann; B Moss
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

10.  Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme--guanylate intermediate.

Authors:  S Shuman; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  33 in total

1.  Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.

Authors:  C L Lin; C S Chung; H G Heine; W Chang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.

Authors:  Wolfgang Resch; Bernard Moss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

5.  Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.

Authors:  A L Passarelli; G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  cis- and trans-acting elements involved in reactivation of vaccinia virus early transcription.

Authors:  K Masternak; R Wittek
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Structure-Based Deep Mining Reveals First-Time Annotations for 46 Percent of the Dark Annotation Space of the 9,671-Member Superproteome of the Nucleocytoplasmic Large DNA Viruses.

Authors:  Yeva Mirzakhanyan; Paul David Gershon
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

8.  Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.

Authors:  E J Wolffe; D M Moore; P J Peters; B Moss
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

10.  DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.

Authors:  M C Cassetti; M Merchlinsky; E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.